SUMMARY: Pam McClure, una beneficiaria de Medicare de 70 años, anticipa ahorrar casi $4,000 en medicamentos gracias a la Ley de Reducción de la Inflación (IRA) de 2022, que limita los gastos de bolsillo a $2,000 en 2025. La ley también reduce copagos de insulina y permite que Medicare negocie precios. Sin embargo, algunos planes incrementarán sus primas significativamente. El período de inscripción anual comenzó el 15 de octubre y finalizará el 7 de diciembre; los beneficiarios deben comparar planes para evitar sorpresas y costos más altos. La IRA introduce cambios significativos en la cobertura de medicamentos de Medicare.

Read the full article

The post Beneficiarios de Medicare gastarán menos en medicamentos en 2025 appeared first on kffhealthnews.org

SUMMARY: Pam McClure is set to save nearly $4,000 on her prescription drugs next year due to new Medicare regulations under the Biden administration’s Inflation Reduction Act (IRA). Starting in 2025, out-of-pocket costs for Medicare enrollees will be capped at $2,000, significantly helping many, including the 3.2 million affected seniors. While some Medicare drug plan premiums will decrease, many will see increases, leading to concerns among beneficiaries. The IRA also introduces a $35 copayment limit for insulin and enables price negotiations with pharmaceutical companies. As enrollment begins, beneficiaries are advised to evaluate their options carefully to avoid missing potential savings.

Read the full article

The post Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More. appeared first on kffhealthnews.org

SUMMARY: Lisa Trumble, reliant on IV nutrition due to severe intestinal issues, faced a sudden hospital discharge cancellation when CVS stopped providing her home care. With 25,000 U.S. patients similarly affected, Hurricane Helene’s destruction of a key North Carolina factory exacerbated an existing IV fluid shortage. CVS’s subsidiary Coram exited the parenteral nutrition and IV antibiotic market, leaving many patients without critical supplies. Despite FDA emergency measures, replenishing supplies remains uncertain. Patients like Trumble, as well as their families, are struggling with health risks and financial strains during this crisis, highlighting the urgent need for reliable infusion care.

Read the full article

The post Helene and CVS Land Double Whammy for 25,000 Patients Who Survive on IV Nutrition appeared first on kffhealthnews.org